naion semaglutide news Beware of Sensationalizing the Potential Semaglutide-NAION Link naion glp-1 news The NAION

Description

"Skinny-shot" injections administered weekly are relatively safe and completely reversible when used by mildly overweight to severely obese patients to treat feeding and eating disorders

Generic alternatives to Ozempic Various GLP-1 receptor agonists are available for managing Type 2 diabetes or supporting weight loss

Just one step at a time in the right direction

A meta-analysis study of 8 clinical trials, including over 60,000 patients with a primary outcome of major adverse cardiovascular events, found an overall GLP-1 medication reduction rate of 14% [22]

16.1% on semaglutide Tirzepatide was superior on all five key secondary endpoints Gastrointestinal discontinuation rate was lower with tirzepatide (2.7%) than semaglutide (5.6%) These findings were consistent across all patient subgroups, regardless of sex, age, baseline BMI, or presence of metabolic comorbidities